Margaret McGlynn
Director/Board Member at AMICUS THERAPEUTICS, INC.
Net worth: 688 770 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Trizzino | M | 64 | 10 years | |
| Bradley Campbell | M | 48 | 18 years | |
| Reshma Kewalramani | M | 51 | 7 years | |
| Seifi Ghasemi | M | 80 | 11 years | |
| Melissa Schaeffer | F | 44 | 8 years | |
| Mike Raab Raab | M | 59 | 20 years | |
| John Jacobs | M | 57 | 1 years | |
| James Young | M | 71 | 14 years | |
| Brian Rosen | M | - | 9 years | |
| Diana McKenzie | F | 59 | 4 years | |
| Suketu Upadhyay | M | 55 | 2 years | |
| Silvia Taylor | F | - | 4 years | |
| Stuart Arbuckle | M | 58 | 12 years | |
| Ellen Rosenberg | F | 61 | 8 years | |
| Lisa Davis | F | 59 | 4 years | |
| Tom Glocer | M | 63 | 17 years | |
| Carmen Bozic | M | 61 | 5 years | |
| Samir Serhan | M | 63 | 8 years | |
| Sangeeta Bhatia | M | 55 | 9 years | |
| Eiry Roberts | M | 60 | 3 years | |
| Jill Weimer | M | - | 5 years | |
| Frank Glavin | M | - |
Orphan Technologies Ltd.
 Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | 15 years |
| Joy Liu | F | - | 8 years | |
| Kristen Ambrose | F | 47 | 3 years | |
| Dalton Smart | M | 58 | 15 years | |
| Edward Atkinson | M | 58 | 4 years | |
| Edward Monser | M | 74 | 11 years | |
| James Kelly | M | 58 | 3 years | |
| Gale Smith | M | - | 20 years | |
| Burke Whitman | M | 68 | 5 years | |
| Matthew Paull | M | 73 | 11 years | |
| Sean Major | M | 60 | 7 years | |
| Alan Garber | M | 68 | 7 years | |
| Richard Rodgers | M | 57 | 2 years | |
| Gregg Alton | M | 58 | 4 years | |
| Mark Joseph Casey | M | 60 | 1 years | |
| Lynn Bleil | F | 60 | 6 years | |
| Peter Wendell | M | 73 | 21 years | |
| Vin Milano Milano | M | 60 |
Life Science Cares Philadelphia
| - |
| David Mott | M | 58 | 4 years | |
| Michael Kelly | M | 67 | 4 years | |
| Charles Cogut | M | 77 | 9 years | |
| Richard Douglas | M | 71 | 14 years | |
| Hing Yuen Ho | M | 65 | 11 years | |
| David Altshuler | M | 59 | 12 years | |
| Glenn Sblendorio | M | 68 | 18 years | |
| Rachel King | F | 64 | 6 years | |
| Benjamin Hussa | M | - | 14 years | |
| Craig Wheeler | M | 63 | 8 years | |
| Lloyd Carney | M | 62 | 5 years | |
| Filip Dubovsky | M | 59 | 4 years | |
| Andrew Faughnan | M | - | - | |
| Eric Paul Goosby | M | - |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 11 years |
| Troy Morgan | M | - | 3 years | |
| Purnima Mane | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 12 years |
| Deborah Ramsdell | F | - |
Orphan Technologies Ltd.
Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | 9 years |
| Allison Boyle | F | - |
Abington Friends School
 Abington Friends School Other Consumer ServicesConsumer Services Abington Friends School provides primary and secondary education services. The company was founded in 1697 by John Barnes and is headquartered in Jenkintown, PA. | - |
| Kathy Dwyer | F | - |
Abington Friends School
Abington Friends School Other Consumer ServicesConsumer Services Abington Friends School provides primary and secondary education services. The company was founded in 1697 by John Barnes and is headquartered in Jenkintown, PA. | - |
| Mark Bunnage | M | - | 8 years | |
| Andreas Sidler | M | - |
Orphan Technologies Ltd.
Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert P. Luciano | M | - | 23 years | |
| Richard Kogan | M | 81 | 21 years | |
| Daphne Quimi | F | 58 | 18 years | |
| Stanley Erck | M | 76 | 14 years | |
| Gary Evans | M | 67 | 23 years | |
| John D. Stanley | M | 66 | 28 years | |
| John Crowley | M | 57 | 22 years | |
| Laura Sepp-Lorenzino | M | 63 | 18 years | |
| Fred Hassan | M | 78 | 6 years | |
| Jeffrey Chodakewitz | M | 68 | 9 years | |
| John M. McAdam | M | 49 | 4 years | |
| John Herrmann | M | 58 | 13 years | |
| Richard Clark | M | 77 | 6 years | |
| John Jones | M | 73 | 36 years | |
| Donald Hayden | M | 68 | 12 years | |
| Joshua Boger | M | 72 | 28 years | |
| TY Howton | M | 52 | 3 years | |
| John McGlade | M | 70 | 38 years | |
| Paul Silva | M | 58 | 14 years | |
| Stephen Jones | M | 62 | 22 years | |
| Sol Barer | M | 76 | 8 years | |
| Matt Patterson | M | 52 | 6 years | |
| Paul Huck | M | 74 | 34 years | |
| Hung Do | M | 55 | - | |
| Mohan Ganesan | M | 56 | 4 years | |
| Richard Henriques | M | 68 | 27 years | |
| Lynn Minella | F | 66 | 8 years | |
| Michael Barrett | M | 81 | 6 years | |
| S. Schaeffer | F | 55 | 7 years | |
| James Topper | M | 62 | 11 years | |
| Russell Wilson | M | 64 | 12 years | |
| William Harrison | M | 80 | - | |
| Geoffrey P. Gilmore | M | 58 | 4 years | |
| Wendy Yarno | F | 69 | 9 years | |
| Arthur Katsaros | M | 76 | 11 years | |
| W. Douglas Brown | M | 78 | 32 years | |
| Kenneth W. Peist | M | 60 | 4 years | |
| Ursula O. Fairbairn | F | 80 | 16 years | |
| Anne Tatlock | F | 84 | - | |
| Rochelle Lazarus | F | 76 | 16 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 97 | 97.00% |
| Switzerland | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Margaret McGlynn
- Personal Network
